Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Conditions
Interventions
Tofacitinib 2 mg
Tofacitinib 5 mg
+2 more
Locations
67
United States
Desert Medical Imaging
Indian Wells, California, United States
Desert Medical Advances
Palm Desert, California, United States
Arthritis & Rheumatology Associates
Clearwater, Florida, United States
Millennium Research
Ormond Beach, Florida, United States
Southwest Florida Clinical Research Center
Tampa, Florida, United States
Covance Central Laboratory Services,Inc
Indianapolis, Indiana, United States
Start Date
April 1, 2013
Primary Completion Date
March 1, 2015
Completion Date
March 1, 2015
Last Updated
June 10, 2016
NCT04402086
NCT07261644
NCT04751396
NCT06707194
NCT06988813
NCT05866614
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions